DE602006009138D1 - 3-amino-2-arylpropylazaindole und anwendungen davon - Google Patents
3-amino-2-arylpropylazaindole und anwendungen davonInfo
- Publication number
- DE602006009138D1 DE602006009138D1 DE602006009138T DE602006009138T DE602006009138D1 DE 602006009138 D1 DE602006009138 D1 DE 602006009138D1 DE 602006009138 T DE602006009138 T DE 602006009138T DE 602006009138 T DE602006009138 T DE 602006009138T DE 602006009138 D1 DE602006009138 D1 DE 602006009138D1
- Authority
- DE
- Germany
- Prior art keywords
- arylpropylazaindole
- amino
- applications
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/14—Ortho-condensed systems
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US74127205P | 2005-11-30 | 2005-11-30 | |
PCT/EP2006/068650 WO2007062998A1 (en) | 2005-11-30 | 2006-11-20 | 3-amino-2-arylpropyl azaindoles and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
DE602006009138D1 true DE602006009138D1 (de) | 2009-10-22 |
Family
ID=37667384
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE602006009138T Active DE602006009138D1 (de) | 2005-11-30 | 2006-11-20 | 3-amino-2-arylpropylazaindole und anwendungen davon |
Country Status (17)
Country | Link |
---|---|
US (2) | US7638517B2 (de) |
EP (1) | EP1957488B1 (de) |
JP (1) | JP2009517432A (de) |
KR (1) | KR101026570B1 (de) |
CN (1) | CN101321752A (de) |
AR (1) | AR057188A1 (de) |
AT (1) | ATE442368T1 (de) |
AU (1) | AU2006319233B9 (de) |
BR (1) | BRPI0619184A2 (de) |
CA (1) | CA2632284A1 (de) |
DE (1) | DE602006009138D1 (de) |
ES (1) | ES2329413T3 (de) |
NO (1) | NO20082112L (de) |
RU (1) | RU2008120141A (de) |
TW (1) | TW200804376A (de) |
WO (1) | WO2007062998A1 (de) |
ZA (1) | ZA200804299B (de) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2912744B1 (fr) * | 2007-02-16 | 2012-09-07 | Centre Nat Rech Scient | Composes pyrrolo°2,3-b!pyridine,composes azaindoles utiles dans la synthese de ces composes pyrrolo°2,3-b!pyridine, leurs procedes de fabrication et leurs utilisations. |
US7871802B2 (en) * | 2007-10-31 | 2011-01-18 | E.I. Du Pont De Nemours And Company | Process for enzymatically converting glycolonitrile to glycolic acid |
CN102026988B (zh) * | 2008-06-05 | 2013-07-03 | 爱思开生物制药株式会社 | 3-取代的丙胺化合物 |
US8101642B2 (en) | 2008-06-05 | 2012-01-24 | Sk Biopharmaceuticals Co., Ltd. | 3-substituted propanamine compounds |
EP2356116A1 (de) | 2008-11-20 | 2011-08-17 | OSI Pharmaceuticals, Inc. | Substituierte pyrrolo[2,3-b]pyridine und pyrazine |
US8222416B2 (en) * | 2009-12-14 | 2012-07-17 | Hoffmann-La Roche Inc. | Azaindole glucokinase activators |
AR081039A1 (es) | 2010-05-14 | 2012-05-30 | Osi Pharmaceuticals Llc | Inhibidores biciclicos fusionados de quinasa |
JP2013526570A (ja) * | 2010-05-14 | 2013-06-24 | オーエスアイ・ファーマシューティカルズ,エルエルシー | 縮合二環式キナーゼ阻害剤 |
WO2012158658A1 (en) | 2011-05-16 | 2012-11-22 | OSI Pharmaceuticals, LLC | Fused bicyclic kinase inhibitors |
AR098436A1 (es) * | 2013-11-19 | 2016-05-26 | Actelion Pharmaceuticals Ltd | Compuestos tricíclicos de piperidina |
CN108034283B (zh) * | 2017-12-15 | 2020-10-13 | 淮海工学院 | 一种聚乙二醇化苯并吲哚七甲川菁染料及其制备方法和应用 |
WO2020160174A1 (en) * | 2019-01-29 | 2020-08-06 | Universita Degli Studi Di Padova | Uses of compounds having anti-hsv-1 activity |
Family Cites Families (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB705652A (en) | 1948-10-01 | 1954-03-17 | Farbewerke Hoechst Ag | Manufacture of 3-aminopropane compounds |
DE849108C (de) | 1948-10-01 | 1952-09-11 | Hoechst Ag | Verfahren zur Herstellung von 1-disubstituierten 3-Aminopropanen |
NL82464C (de) * | 1952-01-05 | |||
US2708197A (en) * | 1952-05-24 | 1955-05-10 | Upjohn Co | Preparation of (hydroxy-3-indole)-alkylamines |
US2984670A (en) * | 1959-05-22 | 1961-05-16 | Upjohn Co | Novel 3-(1-hydroxy-1-phenyl-3-aminopropyl) indoles |
GB992731A (en) | 1962-09-28 | 1965-05-19 | Koninklijke Pharma Fab Nv | Aminoalkyl-indolyl-benzyl alcohols |
US4616080A (en) | 1984-07-02 | 1986-10-07 | Eli Lilly And Company | Simplified process of forming crystalline ceftazidime pentahydrate |
US4956388A (en) * | 1986-12-22 | 1990-09-11 | Eli Lilly And Company | 3-aryloxy-3-substituted propanamines |
KR880007433A (ko) * | 1986-12-22 | 1988-08-27 | 메리 앤 터커 | 3-아릴옥시-3-치환된 프로판아민 |
ATE115953T1 (de) * | 1987-12-11 | 1995-01-15 | Mitsui Petrochemical Ind | Amine und deren verwendung. |
JPH0314562A (ja) | 1988-04-11 | 1991-01-23 | Nippon Chemiphar Co Ltd | 新規なアルキレンジアミン誘導体およびグルタミン酸遮断剤 |
US4902710A (en) * | 1988-12-14 | 1990-02-20 | Eli Lilly And Company | Serotonin and norepinephrine uptake inhibitors |
FR2674522B1 (fr) | 1991-03-26 | 1993-07-16 | Lipha | Nouveaux derives de l'indole, procedes de preparation et medicaments les contenant. |
US5177088A (en) | 1991-04-17 | 1993-01-05 | Hoechst-Roussel Pharmaceuticals Incorporated | Substituted 3-(pyridinylamino)-indoles |
US5185350A (en) | 1991-09-23 | 1993-02-09 | Hoechst-Roussel Pharmaceuticals Incorporated | Substituted pyridinylamino-1h-indoles,1h-indazoles,2h-indazoles, benzo (b)thiophenes and 1,2-benzisothiazoles |
EP0600830A1 (de) | 1992-11-27 | 1994-06-08 | Ciba-Geigy Ag | Substituierte Derivate von Diaminophthalimid als Protein-Tyrosin-Kinase-Hemmer |
GB9225141D0 (en) | 1992-12-01 | 1993-01-20 | Smithkline Beecham Corp | Chemical compounds |
GB9518552D0 (en) | 1995-09-11 | 1995-11-08 | Fujisawa Pharmaceutical Co | New heterocyclic compounds |
GB9523948D0 (en) | 1995-11-23 | 1996-01-24 | Univ East Anglia | Process for preparing n-benzyl indoles |
JPH09176162A (ja) | 1995-12-22 | 1997-07-08 | Toubishi Yakuhin Kogyo Kk | チアゾリジンジオン誘導体及びその製造法並びにそれを含む医薬組成物 |
DE69709647T2 (de) | 1996-05-20 | 2002-11-07 | Teijin Ltd | Cyclischer diarylalkyl diaminederivate als antogoniste von chemokinerezeptoren |
EP0912494A1 (de) | 1996-06-07 | 1999-05-06 | Nps Pharmaceuticals, Inc. | An einer neuen stelle von rezeptorabhängigen kalziumkanälen wirkende verbindungen zur behandlung von neurologischen erkrankungen |
SE9701144D0 (sv) | 1997-03-27 | 1997-03-27 | Pharmacia & Upjohn Ab | Novel compounds, their use and preparation |
EP0887348A1 (de) | 1997-06-25 | 1998-12-30 | Boehringer Mannheim Italia S.p.A. | Bis-Indolderivative mit antimetastatischer Wirkung, Verfahren für deren Herstellung und sie enthaltende pharmazeutische Zusammensetzungen |
CA2303830A1 (en) | 1997-09-26 | 1999-04-08 | Merck & Co., Inc. | Novel angiogenesis inhibitors |
WO1999021553A1 (en) | 1997-10-28 | 1999-05-06 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
AU1197299A (en) | 1997-10-28 | 1999-05-17 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
FR2780890B3 (fr) | 1998-07-10 | 2000-09-01 | Sanofi Sa | Utilisation d'une composition pharmaceutique contenant, en association, un antagoniste des recepteurs at1 de l'angiotensine ii et l'indomethacine pour le traitement des glomerulonephrites chroniques |
WO2000002551A2 (en) | 1998-07-13 | 2000-01-20 | Nps Pharmaceuticals, Inc. | Methods and compounds for treating depression |
SE9903998D0 (sv) | 1999-11-03 | 1999-11-03 | Astra Ab | New compounds |
FR2814073B1 (fr) | 2000-09-21 | 2005-06-24 | Yang Ji Chemical Company Ltd | Composition pharmaceutique antifongique et/ou antiparasitaire et nouveaux derives de l'indole a titre de principes actifs d'une telle composition |
CN1235583C (zh) | 2001-03-05 | 2006-01-11 | 特兰斯泰克制药公司 | 用作治疗剂的苯并咪唑衍生物 |
GB0112122D0 (en) * | 2001-05-18 | 2001-07-11 | Lilly Co Eli | Heteroaryloxy 3-substituted propanamines |
WO2003035005A2 (en) | 2001-10-26 | 2003-05-01 | University Of Connecticut | Heteroindanes: a new class of potent cannabimimetic ligands |
WO2003053938A1 (en) | 2001-12-20 | 2003-07-03 | Novo Nordisk A/S | Benzimidazols and indols as glucagon receptor antagonists/inverse agonisten |
WO2003057213A2 (en) | 2001-12-28 | 2003-07-17 | Bayer Pharmaceuticals Corporation | Cyclohexano- and cycloheptapyrazole derivative compounds, for use in diseases associated with the 5-ht2c receptor |
US7244847B2 (en) | 2002-02-06 | 2007-07-17 | Isis Pharmaceuticals, Inc. | Benzimidazole compounds |
NZ534757A (en) * | 2002-03-12 | 2006-07-28 | Merck & Co Inc | Substituted amides |
CA2480856A1 (en) * | 2002-04-05 | 2003-10-23 | Merck & Co., Inc. | Substituted aryl amides |
JP4459629B2 (ja) * | 2002-04-12 | 2010-04-28 | メルク エンド カムパニー インコーポレーテッド | 二環式アミド |
AU2004235923B2 (en) | 2003-05-09 | 2008-01-24 | F. Hoffmann-La Roche Ag | Methyl indoles and methyl pyrrolopyridines as alpha-1 adrenergic agonists |
WO2005005439A1 (en) | 2003-07-09 | 2005-01-20 | Suven Life Sciences Limited | Benzothiazino indoles |
AU2004273865A1 (en) * | 2003-09-18 | 2005-03-31 | Merck & Co., Inc. | Substituted sulfonamides |
CN1871208A (zh) * | 2003-10-30 | 2006-11-29 | 默克公司 | 作为大麻素受体调节剂的芳烷基胺 |
US7517899B2 (en) * | 2004-03-30 | 2009-04-14 | Wyeth | Phenylaminopropanol derivatives and methods of their use |
ES2340180T3 (es) * | 2004-06-01 | 2010-05-31 | F.Hoffmann-La Roche Ag | 3-amino-1-arilpropil-indoles como inhibidores de reabsorcion de monoaminas. |
AR056544A1 (es) * | 2005-09-29 | 2007-10-10 | Wyeth Corp | Derivados fenilaminopropanol y metodos de uso de los mismos |
-
2006
- 2006-11-20 BR BRPI0619184-3A patent/BRPI0619184A2/pt not_active IP Right Cessation
- 2006-11-20 EP EP06819602A patent/EP1957488B1/de not_active Not-in-force
- 2006-11-20 JP JP2008542715A patent/JP2009517432A/ja active Pending
- 2006-11-20 AT AT06819602T patent/ATE442368T1/de active
- 2006-11-20 DE DE602006009138T patent/DE602006009138D1/de active Active
- 2006-11-20 WO PCT/EP2006/068650 patent/WO2007062998A1/en active Application Filing
- 2006-11-20 AU AU2006319233A patent/AU2006319233B9/en not_active Ceased
- 2006-11-20 CN CNA2006800451404A patent/CN101321752A/zh active Pending
- 2006-11-20 CA CA002632284A patent/CA2632284A1/en not_active Abandoned
- 2006-11-20 ES ES06819602T patent/ES2329413T3/es active Active
- 2006-11-20 RU RU2008120141/04A patent/RU2008120141A/ru not_active Application Discontinuation
- 2006-11-20 KR KR1020087012919A patent/KR101026570B1/ko not_active IP Right Cessation
- 2006-11-28 TW TW095143987A patent/TW200804376A/zh unknown
- 2006-11-28 AR ARP060105231A patent/AR057188A1/es unknown
- 2006-11-29 US US11/605,729 patent/US7638517B2/en not_active Expired - Fee Related
-
2008
- 2008-05-06 NO NO20082112A patent/NO20082112L/no not_active Application Discontinuation
- 2008-05-19 ZA ZA200804299A patent/ZA200804299B/xx unknown
-
2009
- 2009-11-16 US US12/619,275 patent/US20100056499A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
KR20080064192A (ko) | 2008-07-08 |
AU2006319233A1 (en) | 2007-06-07 |
KR101026570B1 (ko) | 2011-03-31 |
WO2007062998A1 (en) | 2007-06-07 |
TW200804376A (en) | 2008-01-16 |
CN101321752A (zh) | 2008-12-10 |
ATE442368T1 (de) | 2009-09-15 |
CA2632284A1 (en) | 2007-06-07 |
US20070123535A1 (en) | 2007-05-31 |
US7638517B2 (en) | 2009-12-29 |
AU2006319233B9 (en) | 2011-09-29 |
BRPI0619184A2 (pt) | 2011-09-13 |
AU2006319233B2 (en) | 2011-06-02 |
EP1957488B1 (de) | 2009-09-09 |
ES2329413T3 (es) | 2009-11-25 |
JP2009517432A (ja) | 2009-04-30 |
EP1957488A1 (de) | 2008-08-20 |
US20100056499A1 (en) | 2010-03-04 |
AR057188A1 (es) | 2007-11-21 |
RU2008120141A (ru) | 2010-01-10 |
NO20082112L (no) | 2008-06-23 |
ZA200804299B (en) | 2009-04-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE442368T1 (de) | 3-amino-2-arylpropylazaindole und anwendungen davon | |
DE602006005902D1 (de) | Pyy-agonisten und anwendungen davon | |
ATE521638T1 (de) | Gegen angiopoietin-2 gerichtete antikörper und anwendungen davon | |
DE602006020061D1 (de) | Mucin-glycoprotein und anwendung davon | |
DE602006001275D1 (de) | Gassack und Gassackeinrichtung | |
DE602005019098D1 (de) | Tetralin- und indanderivate und deren anwendungen | |
DE602006011234D1 (de) | Airbag und Airbagvorrichtung | |
DK1866339T3 (da) | GTR-bindende molekyler og anvendelser heraf | |
DE602006006879D1 (de) | Airbaganordnung und modulierten airbagaufblasverfahren | |
DE602006005104D1 (de) | Luftsack und Luftsackvorrichtung | |
DE602008003575D1 (de) | Piperidinverbindungen und anwendungen davon | |
DE602006002000D1 (de) | Gassack und Gassackeinrichtung | |
DE602006011600D1 (de) | Audiocodierungseinrichtung und audiocodierungsverfahren | |
DE602006010343D1 (de) | Kombinationsprodukt aus o-desmethylvenlafaxin und bazedoxifen und verwendungen davon | |
DE602006014957D1 (de) | Audiocodierungseinrichtung und audiocodierungsverfahren | |
DE602006000563D1 (de) | Gassack und Gassackeinrichtung | |
DE602006015540D1 (de) | Durchführung und buchse | |
DE602006001781D1 (de) | Verbinder und Verbinderanordnung | |
DE602006010414D1 (de) | Haarknüpfwerkzeug und herstellungsverfahren dafür | |
DE602006016225D1 (de) | Verbinder und Verbinderanordnung | |
DE602006003075D1 (de) | Uracilen und 3-sulfonylisoxazolinen | |
DE602006004152D1 (de) | Verbinder und Verbinderanordnung | |
DE602006001091D1 (de) | Verbinder und Verbinderanordnung | |
DE602006017883D1 (de) | Pipd-papier und daraus hergestellte komponenten | |
DE502005009889D1 (de) | Gehäuse und Gehäuseanordnung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |